Cerebrospinal fluid levels of amyloid beta-protein in Alzheimer's disease: inverse correlation with severity of dementia and effect of apolipoprotein E genotype.

Nitsch, R M; Rebeck, G W; Deng, M; Richardson, U I; Tennis, M; Schenk, D B; Vigo-Pelfrey, C; Lieberburg, I; Wurtman, R J; Hyman, B T

Nitsch, R M; Rebeck, G W; Deng, M; Richardson, U I; Tennis, M; Schenk, D B; Vigo-Pelfrey, C; Lieberburg, I; Wurtman, R J; Hyman, B T.

Affiliation

Nitsch RM; Department of Neurology, Massachusetts General Hospital, Boston, USA.

Ann Neurol ; 37(4): 512-8, 1995 Apr.

Article in En | MEDLINE | ID: mdl-7717688

Subject(s)

Alzheimer Disease/cerebrospinal fluid; Amyloid beta-Peptides/cerebrospinal fluid; Apolipoproteins E/genetics; Aged; Alzheimer Disease/genetics; Alzheimer Disease/physiopathology; Female; Genotype; Humans; Male; Middle Aged; Severity of Illness Index

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Apolipoproteins E / Amyloid beta-Peptides / Alzheimer Disease Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Ann Neurol Year: 1995 Document type: Article

Search on Google

XML

PubMed Links